Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arch Biopartners Inc ACHFF


Primary Symbol: V.ARCH

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.


TSXV:ARCH - Post by User

Post by Riverfolkon Dec 30, 2021 4:25pm
124 Views
Post# 34272113

Todays House Positions

Todays House Positions
House Positions for C:ARCH from 20211230 to 20211230
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 57,330 202,949 3.54 0   57,330 -202,949
9 BMO Nesbitt 20,000 69,615 3.481 0   20,000 -69,615
7 TD Sec 15,288 56,203 3.676 3,140 11,276 3.591 12,148 -44,927
13 Instinet 9,200 32,676 3.552 300 1,050 3.50 8,900 -31,626
53 Morgan Stanley 8,000 31,440 3.93 0   8,000 -31,440
85 Scotia 3,194 11,132 3.485 0   3,194 -11,132
83 Mackie 1,000 3,445 3.445 0   1,000 -3,445
68 Leede 680 2,357 3.466 454 1,658 3.652 226 -699
19 Desjardins 5 17 3.40 0   5 -17
72 Credit Suisse 0   300 1,158 3.86 -300 1,158
18 Echelon 0   400 1,396 3.49 -400 1,396
2 RBC 1,601 5,842 3.649 2,695 9,639 3.577 -1,094 3,797
80 National Bank 1,821 6,292 3.455 3,453 12,218 3.538 -1,632 5,926
39 Merrill Lynch 0   2,105 7,513 3.569 -2,105 7,513
79 CIBC 17,600 62,699 3.562 25,700 91,330 3.554 -8,100 28,631
14 ITG 667 2,324 3.484 17,054 59,716 3.502 -16,387 57,392
1 Anonymous 45,115 161,410 3.578 125,900 451,450 3.586 -80,785 290,040
TOTAL 181,501 648,401 3.572 181,501 648,404 3.572 0 3

<< Previous
Bullboard Posts
Next >>